🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Tablet(s) Serving Size
45 Servings
Multi-Vitamin and Mineral (MVM) Product Type
75% Evidence Coverage

Supplement Facts — Evidence Check

25 mcg (125% DV)
✅ 1.7× RDA — within safe limits 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.025mg UL 0.1mg
100 mcg (83% DV)
✅ Within RDA (0.8× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.1mg
Calcium
1200 mg (92% DV)
600 mg (143% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 600mg

Other Ingredients

Calcium Carbonate Cellulose Di-Calcium Phosphate Stearic Acid Microcrystalline Cellulose Silica Magnesium Stearate Pharmaceutical Glaze

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Directions: Four tablets daily.

⚠️ Warnings & Precautions

Keep out of reach of children.

🧪 Formulation Notes

Calcium, Magnesium, D3 and K2 are vital for the formation of strong bones and teeth. More importantly, they are essential for a healthy strong immune defense. They support muscular growth, healthy heartbeat, healthy gums and the transmission of nerve impulses. They support healthy neural, muscular, blood vessel and cardiovascular function. These critical nutrients not only support countless organs, but each mineral promotes the optimal absorption and utilization of the others.

Free from artificial colors and artificial preservatives. Free from the allergens eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat and sesame.

Gluten free

Cal/Mag/Vit D3 1200 mg/600 mg/25 mcg (1000 IU) with Vitamin K2 100 mcg

Bone Support

Manufactured with the Biotron Process of amino acid chelation.

Additional Information

Keep tightly closed in a cool, dry place.

Product Details

UPC / SKU 0 97467 33647 6
DSLD Entry Date 2023-10-24
Product Type Multi-Vitamin and Mineral (MVM)
Form Tablet or Pill
Brand NaturesPlus
DSLD ID 298289
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →